TrialEuropean radiology experimental2021

Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival-prospective interventional study.

Ahmed A Bessar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.